Methylome and transcriptome functional analysis identifies key biomarkers in ketamine's sustained therapeutic effect on PTSD
Wellington, N. J.; Boucas, A. P.; Schwenn, P. E.; Lagopoulos, J.; Quigley, B. L.; Kuballa, A. V.
Show abstract
BackgroundKetamine has emerged as a rapid-acting therapeutic option for post-traumatic stress disorder (PTSD); however, its ability to sustain long-term therapeutic outcomes remains poorly understood. Identifying molecular biomarkers predictive of a sustained response to ketamine may enhance personalised treatment strategies. This study investigates the epigenetic and transcriptomic precursors underpinning ketamines long-term therapeutic efficacy in PTSD. MethodsThis study utilised data from the Oral Ketamine Trial of PTSD (OKTOP), an open-label, dose-ranging clinical study conducted between 2021 and 2024. Baseline differential DNA methylation and gene expression profiles of sustained responders (clinical response >1 month post-ketamine treatment) were compared against non-responders. Epigenomic and transcriptomic analyses were performed to identify differentially regulated genes associated with ketamine response. ResultsBaseline molecular analyses revealed significant differential methylation and transcriptomic profiles across 112 genes. Key biomarkers included DENND5B (cg02046589), ZFY (cg00272582), PDGFRA (cg21309167), CPT1A (cg10098373), AHRR (cg26076054), RPH3AL (cg17316718), CHI3L1 (cg19081101), UTY (cg04790916), LDHD (cg00004883), TBC1D16 (cg26287152), FAM66A (cg23285059), NME8 (cg02531859), EIF1AY (cg13308744), PCBP3 (cg13695288), PAQR6 (cg03954786), KCNK17 (cg19475903), PLPP2 (cg24452451), ANK1 (cg23668222), LINC00200 (C10ORF139, cg19282259), ALAS2 (cg07471703), ZBP1 (cg06305758), TACSTD2 (cg01821018), and PLEKHH3 (cg24455236). These biomarkers were implicated in pathways related to metabolism, transcriptional regulation, cell signalling, neuronal development, immune response, synaptic plasticity, and cytoskeletal organisation. Non-responders exhibited persistent dysregulation across these pathways, suggesting potential biological barriers to treatment efficacy. Clinically, sustained responders presented with higher baseline PTSD severity and demonstrated a response at lower ketamine doses compared to non-responders. ConclusionsThis study highlights the potential of methylomic and transcriptomic profiling to identify functional biomarkers predictive of ketamine response in PTSD. The observed molecular distinctions between responders and non-responders suggest a complex interplay between clinical presentation and treatment outcomes. These findings contribute to advancing precision medicine approaches for PTSD by informing biomarker-driven treatment stratification and optimisation of ketamine therapy.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Neurovegetative symptom subtypes in young people with major depressive disorder and their structural brain correlates 95%
- Alterations in Acylcarnitines, Amines, and Lipids Inform about Mechanism of Action of Citalopram/Escitalopram in Major Depression 94%
- Association between DNA Methylation Levels in Brain Tissue and Late-Life Depression in Community-Based Participants 94%
Similar papers in this journal
- GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia 93%
- Increased functional coupling of the mu opioid receptor in the anterior insula of depressed individuals 93%
- Facilitating mGluR4 activity reverses the long-term deleterious consequences of chronic morphine exposure 93%
Similar papers in this journal
- Transcranial Focused Ultrasound Targeting the Default Mode Network for the Treatment of Depression 93%
- Responsivity of the striatal dopamine system to methylphenidate – a within-subject I-123-ß-CIT-SPECT study in children and adolescents with Attention-Deficit/Hyperactivity Disorder 92%
- Evidence for altered neural activity patterns after MDMA-assisted therapy in adults with chronic and severe post-traumatic stress disorder: a pilot study 91%
Similar papers in this journal
- Ketamine improves anhedonic phenotypes across species: Translational evidence from the Probabilistic Reward Task 94%
- Altered physiological, affective, and functional connectivity responses to acute stress in patients with alcohol use disorder 94%
- Prenatal Selective Serotonin Reuptake Inhibitor Exposure, Depression and Brain Morphology in Middle Childhood: Results from the ABCD Study 92%
Similar papers in this journal
- The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice 93%
- Interrelations Between Dopaminergic-, GABAergic- and Glutamatergic Neurotransmitters in Antipsychotic-Naïve Psychosis Patients and the Association to Initial Treatment Response 93%
- Effect of Non-invasive Spinal Cord Stimulation in Unmedicated Adults with Major Depressive Disorder: A Pilot Randomized Controlled Trial and Induced Current Flow Pattern 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.